Differentiation of IDH-mutant Glioma Subtypes Using Unsupervised Dimensionality Reduction of MRI Biomarkers
Willms K, Zeevi T, Chadha S, von Reppert M, Lost J, Tillmanns N, Merkaj S, Huttner A, Aneja S, Aboian M. Differentiation of IDH-mutant Glioma Subtypes Using Unsupervised Dimensionality Reduction of MRI Biomarkers. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2024 DOI: 10.58530/2024/3094.Peer-Reviewed Original ResearchReevaluating the Role of T2/FLAIR Mismatch Sign: Improving Diagnostic Accuracy With Qualitative MRI Features?
Willms K, von Reppert M, Lost J, Tillmanns N, Merkaj S, Huttner A, Schrickel E, Memon F, Aboian M. Reevaluating the Role of T2/FLAIR Mismatch Sign: Improving Diagnostic Accuracy With Qualitative MRI Features? Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2024 DOI: 10.58530/2024/3586.Peer-Reviewed Original ResearchT2/FLAIR mismatch signIDH-mutant gliomasT2/FLAIR-mismatchVASARI featuresDiagnostic accuracyAccurate preoperative diagnosisIDH-mutant astrocytomasAccurate patient managementQualitative MRI featuresImproving diagnostic accuracyPreoperative diagnosisIDH-mutantImproved diagnostic toolsMRI featuresEnhanced diagnostic methodMismatch signGlioma subtypesPatient managementGlioma cohortGliomaNoninvasive methodDiagnostic precisionDiagnostic methodsDiagnostic toolAstrocytoma